Coenzyme Q 0 (Q 0 ), a strong electrophile, is toxic to insulin-producing cells. Q 0 was incubated with rat and human pancreatic islets and INS-1 insulinoma cells, and its attachment to cellular proteins was studied with Western analysis using antiserum raised against the benzoquinone ring structure of ubiquinone (anti-Q). Q 0 covalently bonded to two proteins, one of 50 kDa and another of 70 kDa. Both proteins were found to be mitochondrial in human and rat islet cells and in many rat organs. Mitochondria were incubated with Q 0 , and affinity-purified anti-Q was used to immunoprecipitate the 50-kDa protein. Amino acid sequencing identified it as dihydrolipoamide succinyltransferase, the E2 component of the ␣-ketoglutarate dehydrogenase complex (KDC). Western analysis also showed that Q 0 bonds to the E2 components of the purified KDC and the pyruvate dehydrogenase complex (PDC). Dihydrolipoamide acetyltransferase, the E2 of the PDC, has a molecular mass of 70 kDa, and the 70-kDa protein was inferred to be this enzyme. Q 0 was found to bond only to proteins containing dihydrolipoate, and in preparations of mitochondria, thiol reducing agents facilitated the attachment of Q 0 , but oxidizing agents prevented it, suggesting that Q 0 bonds to thiols of dihydrolipoamide. Incubation of human or pig PDC with Q 0 followed by matrix-assisted laser desorption ionization time-of-flight and liquid chromatography/electrospray ionization mass spectrometry analyses of chymotrypsin-digested peptides of PDC E2 confirmed that Q 0 bonds to the dihydrolipoamide in these proteins. In mitochondria, coenzymes Q 1 and Q 2 did not bond to the 50-kDa protein but competed with the bonding of Q 0 to this protein. The prevention by Q 1 of the bonding of Q 0 to KDC E2, as well as other characteristics of the Q 0 effect, are reminiscent of the action of Q 0 on the mitochondrial permeability transition pore described previously (Fontaine, E., Ichas, F., and Bernardi, P. (1998) J. Biol. Chem. 273, 25734 -25740).
(9 -11).
To learn more about the roles of quinones in these processes, we raised antisera to the ring structure of ubiquinone (anti-Q antibodies) and used them in Western analysis and for immunoprecipitation. This enabled us to identify several intracellular proteins to which Q 0 , an ubiquinone analog, covalently attached.
Numerous studies have implicated the PTP in apoptosis and cell death (12, 13) , and Bernardi and co-workers (14, 15) observed that a ubiquinone binding site regulates the PTP. They found that Q 0 was a potent inhibitor of calcium-dependent opening of the PTP and that Q 0 was more potent than all other ubiquinone analogs including endogenous quinones (14) . They additionally showed that electron flux through complex I of the respiratory chain is an important PTP regulator and that when complex I is turning over, Q 0 becomes an even more potent inhibitor of the PTP (16) , and they suggested that Q 0 binds to sites previously occupied by endogenous quinones. Numerous ubiquinone analogs in which carbon 6 of the benzoquinone ring is occupied by various side chains were ineffective as PTP inhibitors, except for decylubiquinone, which was less potent than Q 0 . Bernardi and co-workers (14) also observed that Q 1 , which did not itself inhibit the PTP, specifically counteracted the inhibitory effect of Q 0 . The PTP is also regulated by the NAD/NADH, NADP/NADPH, and oxidized glutathione/reduced glutathione ratios, with the latter being the most important (17, 18) . Oxidized ratios of pyridine nucleotides and oxi-dized glutathione/reduced glutathione and oxidized vicinal thiol groups favor pore opening (19, 20) .
The current work shows that there are rough similarities between the effects of Q 0 on the PTP (14 -17) and its interactions with two mitochondrial proteins. The absence of a side chain at carbon 6 of the benzoquinone ring of Q 0 enables it to be a potent electrophile that can react with cellular nucleophiles, such as peptide thiols and reduced glutathione, to form a strong carbon sulfur bond. The neighboring oxygen on carbon 1 permits resonance delocalization of the negative charge of the unsaturated bond at carbon 6, allowing a nucleophile to add to carbon 6 in a Michael reaction or a similar reaction.
We observed that Q 0 bonds covalently to two proteins, one of about 50 kDa and another of about 70 kDa, in rat and human pancreatic islets and in INS-1 rat insulinoma cells as judged by Western analysis. The proteins were associated with the mitochondrial inner membrane of these tissues and of numerous rat organs. Although a large amount of Q 0 was found in the two proteins when Q 0 alone was added to mitochondria, prior incubation of mitochondria with a low concentration of dithiothreitol, which keeps thiols reduced, made both proteins more susceptible to Q 0 bonding. In addition, agents such as oxidized dithiothreitol, N-ethylmaleimide, and t-butyl hydroperoxide that can oxidize thiols prevented the attachment of Q 0 . Q 1 did not bond to the proteins, but it and Q 2 inhibited bonding of Q 0 to the 50-kDa protein, similar to the effect of Q 1 preventing the action of Q 0 on the PTP.
The 50-kDa protein was immunoprecipitated from mitochondria using affinity-purified anti-Q antibodies followed by amino acid sequencing of its trypsin-digested peptides and identified as the dihydrolipoamide succinyltransferase (E2) of the ␣-ketoglutarate dehydrogenase complex. At low micromolar concentrations, Q 0 was found to bond to the E2 enzymes of purified ␣-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes. The E2 enzyme of the pyruvate dehydrogenase complex has a molecular mass of 70 kDa, and therefore it was inferred that the 70-kDa protein is the E2 (dihydrolipoamide acetyltransferase) of this complex. Both E2 enzymes are part of multienzyme complexes involved in metabolism of mitochondrial substrates that pass electrons to complex I of the respiratory chain. MALDI-TOF mass spectrometry and liquid chromatography/electrospray ionization mass spectrometry of the dihydrolipoamide acetyltransferase identified two protein fragments that contain lipoate as the targets of Q 0 . Q 0 seems to bond most effectively and specifically to thiols of dihydrolipoamide because even at exceptionally high concentrations, it did not bond to the numerous cysteines in cellular proteins or to cysteines in the two purified E2 proteins. Thus, the results suggest that some of the toxic effects of Q 0 in cells are due to its propensity to attack the dihydrolipoamides of the two acyltransferase enzymes.
EXPERIMENTAL PROCEDURES
Materials-␣-2,3-Dimethoxy-5-methyl-6-(3Ј-carboxy-3Ј-methylpropyl)-1,4-benzoquinone (which we named Q acid) was generously provided by Dr. Masazumi Watanabe (Takeda Chemical Industries, Ltd., Tokyo, Japan). Protein A Trisacryl beads, KLH, and EDC were from Pierce. Q 0 (2,3-dimethoxy-5-methyl-1,4-benzoquinone), glutathioneagarose (catalog number G-0387), S-thiopropyl-Sepharose (catalog number T8387), additional KLH and EDC, and all other chemicals were obtained from Sigma in the highest purity available. Purified porcine heart ␣-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes were from Sigma. These two enzyme complexes purified from bovine heart, as well as recombinant human pyruvate dehydrogenase complex, were gifts of Thomas Roche. Pancreatic islets and other tissues were obtained from 300-g Sprague-Dawley rats as described previously (1, 21) . Human pancreatic islets were from the Islet Isolation Core, Washington University School of Medicine (St. Louis, MO).
Antisera to Q Acid-Q acid was conjugated to KLH by mixing 0.5 ml of a 10 mM solution of Q acid in 0.9 M NaCl and 0.1 M MES buffer, pH 4.7, with 0.15 ml of 65 mM EDC. After 10 min, the activated Q acid was added to 0.2 ml of KLH (10 mg/ml), and the mixture was allowed to set at room temperature. After 2 h, the unconjugated Q acid was removed from the Q acid-KLH conjugate by gel filtration as described in the Pierce Immunogen EDC Conjugation Kit instructions. The conjugate was mixed with Freund's adjuvant, and 0.5-1.0 mg of hapten protein was injected into rabbits at 6-week intervals four times and again a fifth time after a year. Antisera were harvested 3 weeks after the third, fourth, and fifth injections of hapten. Subcellular Fractionation-Organs were homogenized in 220 mM mannitol, 70 mM sucrose, and 5 mM potassium Hepes buffer, pH 7.5 (MSH), and centrifuged at 600 ϫ g for 10 min to obtain a pellet of nuclei and cell debris. The resulting supernatant fraction was centrifuged at 5,500 ϫ g (islets) or 15,000 ϫ g (other tissues) for 10 min to obtain the mitochondrial pellet. Mitochondrial pellets from large tissues were resuspended in MSH and washed three times by centrifugation. Islet mitochondrial pellets were washed once. The post-mitochondrial supernatant fraction was centrifuged at 21,000 ϫ g for 10 min to obtain a supernatant fraction consisting of cytosol plus endoplasmic reticulum (21, 22) .
Incubation of Tissues with Q 0 -Intact islets were incubated in KrebsRinger bicarbonate buffer, pH 7.3. Homogenates of whole tissue and subcellular fractions were incubated with various concentrations of Q 0 in MSH solution for 30 min or for 1 h at room temperature. When added, dithiothreitol or Q 1 , Q 2 , doxorubicin, genistein, 1,4-benzoquinone, aurovertin, or infrapeptin was present for 15 min before the addition of Q 0 to mitochondria and also present during incubation with Q 0 . When added, N-ethylmaleimide, oxidized dithiothreitol (trans-4,5-dihydroxy-1,2-dithiane), or t-butylhydroperoxide was incubated with mitochondria for 1 h at room temperature and washed out by centrifugation of the mitochondria before Q 0 was added. Compounds not soluble in aqueous buffers were dissolved in dimethyl sulfoxide and added to the aqueous mixture to give a final concentration of dimethyl sulfoxide of Յ1%.
Extraction of Proteins from Mitochondria-After mitochondria from various tissues were incubated with Q 0 , the mitochondria were centrifuged at 15,000 ϫ g for 10 min, and the resulting pellet (about 600 l) was suspended in 12 volumes of 20 mM sodium phosphate buffer, pH 7.5, containing 10 mM Triton X-100 and vortexed at room temperature for 1 h. The mixture was then centrifuged at 20,000 ϫ g for 10 min, and the supernatant fraction containing the Q 0 -bonding proteins was saved for analysis . It was subsequently learned that a large amount, albeit less, of the 50-kDa protein could be extracted without Triton X-100. The Triton X-100 was omitted when the sample was used for immunoprecipitation.
Immunoblotting-After incubation with Q 0 , pancreatic islets were washed and boiled in gel electrophoresis sample buffer (1.7% SDS, 5% glycerol, 62 mM Tris-chloride buffer, pH 6.8, and 100 mM dithiothreitol). Mitochondrial proteins were solubilized with 10 mM Triton X-100 in 20 mM sodium phosphate buffer, pH 7.5, and boiled in sample buffer. Proteins were separated by SDS-PAGE in 10% polyacrylamide gels and electrotransferred to nitrocellulose membranes that were probed with polyclonal antibodies to Q 0 . The antiserum from rabbit 73613 was used at a dilution of 1:6,000, and the antiserum from rabbit 73903 was used at a dilution of 1:500. Protein bands were visualized by chemiluminescence with the ECL Western blotting system (Amersham Biosciences).
Immunoprecipitation and Identification of the 50-kDa Q 0 Bonding Protein-Affinity-purified antibodies were used to immunoprecipitate one of the proteins to which Q 0 bonds. Q 0 was immobilized on a solid support of 3 ml of either settled oxidized glutathione-agarose beads or S-thiopropyl-Sepharose beads. The beads were treated with 12 ml of 100 mM dithiothreitol for 1 h and washed five times with 12 ml of water. Q 0 (40 mM, 12 ml) was added to the beads, and they were agitated gently for 18 h on a rocking platform. Beads were washed five times with water and twice with Tris-buffered saline (50 mM Tris-chloride, pH 7.5, and 150 mM NaCl). To affinity-purify the anti-Q antibodies, the beads were suspended in 4 -8 ml of anti-Q serum from rabbit 73613 plus 4 -7 ml of Tris-buffered saline and agitated gently for 18 h. Beads were washed five times with Tris-buffered saline and then sequentially treated for 15 min with 12 ml each of three different buffer solutions to elute the anti-Q antibodies: 100 mM glycine, pH 3.0; Tris-buffered saline; and 100 mM triethylamine, pH 11.5. Immediately after elution, the pH of each fraction was adjusted to 7.5 by adding 1 M Tris chloride to give a concentration of 0.2 M, and bovine serum albumin was added to give a concentration of 5 mg/ml. Western analysis indicated that the triethylamine eluate contained Ͼ90% of the anti-Q antibodies.
Affinity-purified anti-Q antibodies were covalently coupled to 2-3 ml of protein A Trisacryl beads as described previously (23) . Briefly, beads were washed three times with 10 volumes of 200 mM sodium borate buffer, pH 9.0, and incubated with all three of the elutant fractions of affinity-purified anti-Q antibodies. After 20 h, the beads were washed five times with 10 volumes of borate buffer and incubated in 10 volumes of 20 mM dimethylpimelimidate in the borate buffer. After 1 h, the beads were washed with borate buffer twice, and 10 volumes of 0.2 M ethanolanine, pH 8.7, were added to block any unreacted sites. After gentle agitation for 20 h, the beads were washed five times with 10 volumes of Tris-buffered saline and saved until use.
To immunoprecipitate the Q 0 -bonding protein, anti-Q-protein A Trisacryl beads were incubated for 18 h with 10 -15 volumes of kidney mitochondrial supernatant fraction that had been extracted in 20 mM potassium phosphate buffer, pH 7.5. The extract was the supernatant fraction prepared by vortexing the mitochondria in 20 mM potassium phosphate buffer at room temperature for 1 h and removing the mitochondrial membranes by centrifuging the mixture for 10 min at 20,000 ϫ g. The beads were washed five times with Tris-buffered saline and boiled in 1.5 volumes of SDS sample buffer in preparation for gel electrophoresis. After electrophoresis, the protein in the gel was stained with 0.1% Coomassie Blue R-250 in 10% acetic acid and 10% methanol for 15 min or electrotransferred to nitrocellulose for Western analysis. The Coomassie Blue R-250-stained band was excised from the gel and digested with trypsin, the internal peptides were separated by HPLC, and their amino acid sequences were determined with an Applied Biosystems Procise cLC Protein Sequencing System.
Mass Spectrometry of Peptides-Human and pig pyruvate dehydrogenase complexes were dialyzed into a solution of 20% glycerol, 1 mM EDTA, 50 M dithiothreitol, and 25 mM potassium phosphate buffer, pH 7.5, and incubated with or without Q 0 , and the component proteins were separated by SDS-PAGE. The gel band was excised, cut into 1-mm 3 pieces, alkylated with iodoacetamide, and then incubated for 22 h with 20 g of chymotrypsin or chymotrypsin followed by trypsin in 50 mM ammonium bicarbonate buffer, pH 8.0. The digested peptides were extracted by sonication in 20 l of 60% acetonitrile and 1% trifluoroacetic acid for 15 min, and then the supernatant fraction was concentrated in vacuo to 10 l. For MALDI-TOF MS, 0.5 l of the extract was mixed with 0.5 l of saturated ␣-cyano-4-hydroxycinnamic acid matrix solution in 0.1% trifluoroacetic acid in 60% acetonitrile, air-dried, and introduced into the spectrometer. Spectra were obtained on a Voyager-DE STR MALDI-TOF mass spectrometer (PerSeptive Biosystems, Inc., Framingham, MA) in the linear mode. Time to mass calibration was achieved using bradykinin (MH ϩ at 1061.2 Da) and insulin MH ϩ at m/z 5734.59 Da. Average masses of all possible peptide fragments of the completely and incompletely digested proteins were calculated with the program Protein Prospector (http://prospector.ucsf.edu). Liquid chromatography/MS was performed on a Capillary liquid chromatography system (Waters Corp., Milford, MA) coupled to a LCQ DECA ion trap mass spectrometer (Thermofinnigan, San Jose, CA) equipped with a nanospray ionization source. An aliquot (6.4 l) of the chymotryptic digest was trapped on a Michrom Cap Trap cartridge (Michrom BioResources, Inc., Auburn, CA) and flushed onto a 5 cm ϫ 75 m inner diameter Picofrit column packed with 5 m of ProtoPep C18 material (New Objective, Woburn, MA). Peptides were eluted from the column with a gradient of 2-95% acetonitrile in 0.1% formic acid. Peptides were identified with the program Sequest.
RESULTS
Q Proteins-To study the toxic effects of Q 0 on cells occurring at concentrations that also stimulate insulin release from pancreatic islets, the islets were incubated with 0 -200 M Q 0 . Intracellular Q 0 and/or Q 0 adhering to the outside of the cells was measured by absorbance at 263 nm (versus 274 nm for coenzyme Qs with long side chains) and by Craven's test. This indicated that the intracellular concentration of Q 0 was no more than 45% of the concentration of Q 0 added to the incubation medium. As judged by Western analysis with a late draw of anti-Q antiserum 73613, Q 0 reacted with two proteins with molecular masses of about 50 and 70 kDa (Fig. 1) . Q 0 was also incubated with whole cell homogenates and subcellular fractions of rat and human pancreatic islets and the INS-1 rat insulinoma cell line. A solution containing Triton X-100 was used to extract proteins from the tissue fractions, and the extracts were used for Western analysis. In all three tissues, a protein of 50 kDa was the major reactant when a potent anti-Q antiserum from rabbit 73613 (from an early draw) was used at a dilution of 1:6,000 (Figs. 2-4) . When a weaker anti-Q antiserum from a different rabbit (rabbit 73903) was used (at a dilution of 1:500) to probe the blots, a protein of about 70 kDa was the major reactant ( Figs. 3 and 4) . The initial different specificities of the anti-Q antisera from the two rabbits were puzzling but highly reproducible. It may indicate that the amino acid residues surrounding the Q 0 bonding site were initially part of the epitope for these antisera. In any case, this initial apparent difference in specificity does not influence the arguments made later in the paper and does not influence our final conclusions. Antiserum from the weakly responding rabbit was not used in subsequent experiments because after the fourth and fifth immunizations, the strong antisera reacted with both the 50-and 70-kDa proteins.
Subcellular fractionation indicated that the Q 0 -bonding proteins are mitochondrial proteins (Fig. 2, lane 4; Fig. 3 , lanes 4 -6, top and bottom panels; marker (mitochondrial glycerol phosphate dehydrogenase enzyme activity) is found in nuclei plus cell debris fraction in islets, most likely from unbroken cells (21) . No immunoreactivity was seen in the cytosol fraction, which, because of the way it was deliberately prepared, also contains insulin granules and endoplasmic reticulum (Fig. 2, lane 8; Fig. 3, lanes 11 and 12,  top and bottom panels; Fig. 4, lane 10, left and right panels) .
There was no immunoreactivity in cellular fractions not incubated with Q 0 (Fig. 2, lanes 1, 3, 5 , and 7; Fig. 3, lanes 1, 7, and 10, top and bottom panels; Fig. 4, lanes 1, 3, 5 , 7, and 9 of the left panel and lanes 1, 5, 7 , and 9 of the right panel).
It was initially thought that the 50-and 70-kDa Q 0 -bonding proteins were tightly associated with the inner mitochondrial membrane because after two cycles of freezing and thawing of mitochondria, substantial amounts of the proteins were still present in the pellet of mitochondrial membranes. The proteins could be released from the membranes with detergents, such as Triton X-100 (10 mM) or Nonidet P-40 (0.1%). Triton X-100 solubilized more of the proteins than Nonidet P-40. It was later discerned that a considerable amount (but less) of the immunoreactive 50-kDa protein could be dislodged from the mitochondrial membranes by vigorously vortexing the mitochondria in 20 mM potassium phosphate, pH 7.5, for 1 h without a detergent. Less of the 70-kDa protein than the 50-kDa protein could be solubilized from the mitochondria without detergents.
Tissue Distribution-The 50-kDa Q 0 -bonding protein was present in large amounts in mitochondria of all rat organs studied including heart, liver, kidney, adrenal gland, spleen, lung, skeletal muscle, and brain. High levels of the 70-kDa protein were detected in mitochondria of heart, moderate levels were detected in kidney and brain, and low levels were detected in adrenal gland and skeletal muscle when antiserum 73613 was used for Western analysis (Fig. 5) . It is noteworthy that the tissues that contain high levels of the 70-kDa protein, such as heart, are also the tissues that are known to contain high levels of pyruvate dehydrogenase enzyme activity as discussed below. It was subsequently learned that the 70-kDa protein is a component of the pyruvate dehydrogenase complex.
Concentration Range of Q 0 Bonding-The lowest concentration tested at which Q 0 bonding to the 50-kDa protein of kidney mitochondria was visible by Western analysis was 10 M (data not shown).
Effect of Oxidation/Reduction-Although considerable Q 0 bonded to the two proteins when it was added by itself, adding 100 M dithiothreitol to a tissue homogenate or mitochondria enhanced the reactivity of Q 0 to the 50-and 70-kDa proteins. This suggests that bonding of Q 0 was facilitated by increased availability of protein thiol groups (Fig. 3, lanes 3 and 6, top  and bottom panels) . The idea that Q 0 bonds covalently to thiols was further supported by incubating mitochondria with agents that attack thiols, such as t-butyl hydroperoxide, N-ethylmaleimide, and oxidized dithiothreitol and removing the agents by washing the mitochondria before Q 0 was added. These agents completely or partially inhibited the detection of Q 0 in the proteins (Fig. 6) , suggesting that these agents oxidized the protein's thiols and made them unsusceptible to attack by Q 0 .
Competition from Other Quinones-When Q 1 or Q 2 was incubated with kidney mitochondria, no protein was recognized by the antibody. This was expected because position 6 of these molecules is occupied by an isoprenoid chain, and thus these molecules are not electrophilic and cannot form a covalent bond at carbon 6. However, when Q 1 and Q 2 were co-incubated with Q 0 and mitochondria, they diminished the bonding of Q 0 to the 50-kDa protein, but not to the 70-kDa protein, in rat kidney mitochondria (Fig. 7) . Other compounds that contain a quinone structure, doxorubicin and genestein, did not prevent the bonding of Q 0 to the mitochondrial proteins (data not shown). However, 1,4-benzoquinone prevented the antibody from reacting with both the 50-and 70-kDa proteins (Fig. 8) . Rotenone, a quinone inhibitor of NADH dehydrogenase found in the inner mitochondrial membrane, did not interfere with Q 0 bonding to the proteins (data not shown).
Identity of the 50-kDa Q 0 Protein-Kidney mitochondria were reacted with Q 0 and extracted without detergent as described under "Experimental Procedures." Coomassie Blue staining of the immunoprecipitated and gel-electrophoresed Q 0 -incubated kidney mitochondrial extract revealed a single protein band of about 50 kDa. However, Western analysis, which is far more sensitive than Coomassie Blue staining, showed that a small amount of the 70-kDa protein was precipitated in addition to the 50-kDa protein. It is most likely that the 70-kDa protein was not well extracted from the mitochondria without detergent. Beads incubated with mitochondrial extraction buffer alone or mitochondrial extract previously incubated without Q 0 or with 1,4-benzoquinone did not show any immunoprecipitated proteins that were visible by either Coomassie Blue staining or Western analysis.
The 50-kDa protein band was cut out of the gel and digested with trypsin, the resulting peptides were separated by HPLC, and the amino acid sequences of two of the peptides were determined. The sequences of the peptides (AAPEAPAAPPP-PVAPVPTQMPPVP and GLVVPVIR) corresponded to residues 154 -177 and 315-322 of dihydrolipoamide succinyltransferase (E2) (GenBank TM accession no. BAA14397) of the rat ␣-ketoglutarate dehydrogenase multienzyme complex (KDC). Because this enzyme contains dihydrolipoamide, and the E2 enzyme of the PDC has a molecular mass of 70 kDa and also contains dihydrolipoamide and is very similar to KDC E2, it was asked whether the 70-kDa immunoreactive protein was the E2 enzyme of the PDC. This enzyme contains two lipoate molecules. Western analysis of the purified porcine KDC and PDC (Fig. 9) or bovine enzyme complexes (data not shown) incubated with Q 0 indicated that the antibody reacted with a 50-kDa protein of the KDC and a 70-kDa protein of the PDC. In addition, when a high concentration of PDC was used in immunoblotting, a second ϳ50-kDa protein of the PDC was detected (data not shown). This protein is likely the E3-binding protein of the PDC. It has a molecular mass of about 50 kDa and contains one lipoate molecule. This protein is much less FIG. 6 . Sulfhydryl reagents decrease the bonding of Q 0 to the 50-kDa protein in rat kidney mitochondria. Rat kidney mitochondria (90 g of protein) were incubated with sulfhydryl oxidizing agents for 1 h at room temperature, washed twice by centrifugation, and then incubated with 1 mM Q 0 for 1 h at room temperature and subjected to immunoblot analysis. Blots were probed with an early draw anti-Q antibody from rabbit 73613. Lanes 1 and 2, t-butylhydropheroxide (Butyl), 0.1 and 1 mM; lanes 3 and 4, N-ethylmaleimide (NEM), 0.1 and 1  mM, lanes 5 and 6, oxidized dithiothreitol (oxDTT) ; lane 7, without an oxidizing agent (None).
FIG. 7.
Competition of Q 1 or Q 2 with bonding of Q 0 to proteins of rat kidney mitochondria. Rat kidney mitochondria (100 l of 1 mg/ml mitochondrial protein) were incubated in the absence or presence of Q 1 or Q 2 (added in 10 l of methanol) for 1 h, and then various concentrations of Q 0 were added, and the incubation was continued for a second hour. Twenty l of sample was applied to each well for PAGE followed by immunoblotting. The top and bottom panels each show a separate experiment. Samples in lanes 13 and 14 contained methanol equal to that in samples applied to lanes [5] [6] [7] [8] [9] [10] [11] [12] . The concentration of Q 1 and Q 2 was 1 mM except in mixtures shown in lanes 9, 11, and 12 of the bottom panel, where the concentration of Q 2 was 0.5 mM. Blots were probed with antiserum from a late draw of anti-Q antiserum from rabbit 73613. 9 . Covalent bonding of Q 0 to the E 2 enzymes of ␣-ketoglutarate dehydrogenase and pyruvate dehydrogenase. Porcine ␣-ketoglutarate dehydrogenase multienzyme complex (KGDC) (0.5 g of protein) and 0.9 g of pyruvate dehydrogenase multienzyme complex (PDC) were incubated with various concentrations of Q 0 for 1 h at room temperature and analyzed by Western analysis. The 50-and 70-kDa bands correspond to the E2 enzymes of ␣-ketoglutarate dehydrogenase multienzyme complex and PDC, respectively. The 70-kDa band in the preparation of ␣-ketoglutarate dehydrogenase multienzyme complex is due to its contamination with PDC as judged from our assays of enzyme activities and also as described by the vendor. abundant than the E2 enzyme in the PDC and would be expected to be visible at only high concentrations of the enzyme complex.
Mass Spectrometry Analysis-Results of mass spectrometry studies of pure human and partially pure pig PDC incubated with Q 0 indicated that Q 0 bonds only to the lipoyl domains of the dihydrolipoamide acetyltransferase (E2) component of PDC. The enzyme complexes were incubated with Q 0 followed by SDS-PAGE, and the single peptide band that reacted with anti-Q 0 antibody (the 70-kDa band) as judged from Western analysis was excised and digested with chymotrypsin and subjected to MALDI-TOF MS and electrospray ionization mass spectrometry analysis. Dihydrolipoic acid is known to be covalently attached to the epsilon amino group of the side chain of lysines at positions 99 and 226 of human PDC E2 (Swiss-Prot accession no. P10515). The MALDI-TOF mass spectrum showed two peaks with m/z values that corresponded to modification of the dihydrolipoates with Q 0 as assigned with the aid of the Protein Prospector software program. Peaks with m/z values of 2604.30 and 2724.97 Da were observed in the spectrum of the Q 0 -treated sample that were not present in the spectrum of the sample that was not treated with Q 0 (Fig. 10) . These m/z values match the theoretical masses of chymotryptic petptide fragments 92-111 and 219 -239 of the E2 component modified with Q 0 (mass equal to peptide mass plus masses added by modifications by lipoate (189) and Q 0 (182)). Electrospray ionization mass spectrometry analysis and a Sequest search of the chymotrypsin-digested 70-kDa protein band of Q 0 -treated human PDC followed by trypsin digestion confirmed that PDC E2 was the only major protein in the band and was consistent with the lysines at positions 99 and 226 being modified by lipoate plus Q 0 .
The pig PDC E2 (GenBank TM accession no. BAB61720) is modified by lipoate attached to lysines at positions 132 and 259. The MALDI-TOF mass spectrum of the chymotrypsindigested E2 peptide from the Q 0 -treated PDC showed a peak with an m/z of 5396.83 Da (Fig. 11) . This mass corresponds to that of the consensus amino acid sequence of region 100 -144 of the protein that is modified by lipoate plus Q 0 . No peak with this mass was observed in the spectrum of the sample not treated with Q 0 . Electrospray ionization mass spectrometry analysis of the chymotrypsin-digested pig E2 protein from the pig PDC sample that was not treated with Q 0 followed by a Sequest search done against pig E2 of the PDC found two peptides with lysines modified by lipoate, one at position 132 and the other at position 259, when the search was done to include the relevant lysine modifications. The search ranked these peptides 1 and 2 with respect to peptides with modified lysines. A Sequest search of the electrospray ionization data from the digested pig PDC sample that was treated with Q 0 found a peptide with the lysine at position 259 modified by lipoate plus Q 0 and ranked this peptide number 1 when the search was carried out to include the relevant lysine modifications. The search indicated that the lipoate was also modified by carbamidomethylation arising from the iodacetamide reagent used to prevent dimerization of thiols during the proteolytic digestion of the proteins.
DISCUSSION
In the current study, we incubated human and rodent pancreatic islets or mitochondria from various rat tissues with Q 0 and used immunoblot analysis with antisera against the ring structure of ubiquinone to identify proteins containing covalently attached Q 0 . Two mitochondrial proteins, one of 50 kDa and another of 70 kDa, were detected. The stronger of the two antisera was affinity-purified, and the antibody was used to immunoprecipitate the 50-kDa protein from a kidney mitochondrial extract. By amino acid sequencing of several internal peptides from a tryptic digest of this protein, it was identified as dihydrolipoamide succinyltransferase, the E2 of the KDC.
At 1 M or higher concentrations, Q 0 was then shown to bond to a 50-kDa protein in purified porcine and bovine KDCs and to a 70-kDa protein in preparations of purified porcine and bovine PDCs ( Fig. 9 ; data not shown). Dihydrolipoamide acetyltransferase, the E2 of the pyruvate dehydrogenase complex (PDC), has a molecular mass of 70 kDa, and the native 70-kDa Q 0 -bonding protein was inferred to be this protein. It is noteworthy that although the 50-kDa protein was easily seen in all tissues studied with Western analysis, the 70-kDa protein was more readily visualized in certain tissues, such as heart, kidney, and brain ( Fig. 5) and islets (Fig. 1) . This distribution roughly corresponds to the level of PDC enzyme activity among tissues of the body. The PDC complex also contains the E3-binding protein, which is another protein that contains lipoate and has a molecular mass of about 50 kDa. Q 0 most likely bonds to this protein in addition to the E2 of KDC in intact mitochondria because two separate proteins with slightly different molecular masses of around 50 kDa were detected by Western analysis in extracts of rat kidney mitochondria that were fractionated with hydroxyapetite chromatography (data not shown).
Interestingly, unlike many other quinones or other agents that attack thiols, Q 0 seems to specifically attack only dihydrolipoamide thiols, without attacking cysteine thiols of the same or other proteins. When Q 0 was incubated at concentrations as low as 10 M or as high as 10 mM with intact cells or subcellular fractions of various tissues, it bound only to the mitochondrial proteins later identified as ones known to possess lipoic acid. In addition, mass spectrometric analysis of purified PDC or KDC incubated with Q 0 revealed covalent bonding of Q 0 only to the dihydrolipoates of the E2 enzymes of these complexes and not to cysteines of these proteins. It seems unlikely that this is due solely to steric hindrance of the Q 0 molecule preventing it from attacking cysteine sulfhydryls but allowing it to attack dihydrolipoamide sulfhydryls that extend from the peptide backbone on an 11-atom arm (formed by 4 lysine carbons plus the nitrogen of the amide bond and 6 carbons of lipoate) because even larger quinones with more complex structures, such as vitamin K analogs with bulky side groups (24, 25) , attack cysteine thiols on many proteins. It is possible that, as an ubiquinone analog, the structure of Q 0 enables it to specifically interact with the E2 components of these dehydrogenases when they are present in their native environment in the inner mitochondrial membrane. This idea is supported by the observation that Q 1 and Q 2 (which cannot covalently bond to thiols and therefore do not bond covalently to the 50-or 70-kDa proteins) inhibited Q 0 bonding to the E2 of KDC in mitochondria (Fig. 7) , but not in the purified enzyme complex (data not shown).
Q 0 is often used in studies of mitochondria (14 -19) and apoptosis (10, 11) , and it also stimulates insulin release from isolated pancreatic islets (1, 2) . Like several other similar quinone agents that stimulate insulin release (1-3), such as tyrosine kinase inhibitors (4 -6), Q 0 kills the insulin-producing cell. A quinone with a similar structure, 2,3-dimethoxy-1,4-naphthoquinone, causes Ca 2ϩ overload and depletion of glutathione, ATP, and NAD in rat insulinoma cells, resulting in apoptosis (3) . Some of these deleterious effects of quinones, such as causing Ca 2ϩ overload, may be due to mitochondrial redox cycling, but quinones can also attack thiols, and this very likely accounts for the depletion of cellular glutathione. Interestingly, Q 0 is reported to inhibit the opening of the mitochondrial PTP, and because this is the first step in apoptosis (12, 13) , this should help keep the cell intact (14 -19) . However, it is noteworthy that Q 0 differs from naturally occurring coenzyme Q molecules in that there is no group on carbon 6 except for a hydrogen. This makes Q 0 a very reactive electrophile. The tyrosine kinase inhibitors and 2,3-dimethoxy-1,4-naphthoquinone also have carbons without side groups adjacent to carbonyl groups, also making them strong electrophiles. Some of the ability of Q 0 to inhibit the mitochondrial permeability transition might be due to the fact that it can attack strongly nucleophilic thiol groups and that its ring structure is the same as that of ubiquinone.
Whether or not either of the two E2 enzymes is indirectly involved in the PTP will need to be resolved by future experiments. However, there are rough parallels between the effects of Q 0 on the PTP and its bonding to these proteins. The effect of Q 0 on the PTP involves complex I of the respiratory chain (16) , and the reactions of KDC and PDC each contribute electrons to complex I. Q 0 at low micromolar concentrations is a potent inhibitor of the PTP, and although its inhibiting action on the PTP is prevented by Q 1 , Q 1 itself and other ubiquinone analogs have no effect on the PTP (14 -19) . Similarly, Q 1 and Q 2 do not bond to the E2 proteins, but they do prevent bonding of Q 0 to the E2 protein of KDC. Thiol groups are involved in the PTP, and Q 0 has a strong affinity for thiols. In this regard, it is of interest that aldehydes, such as 4-hydroxynonenal, have been shown to inhibit the PTP (26) and also to selectively inhibit PDC and KDC, most likely by attacking their dihydro- lipoate groups (27, 28) . Because 4-hydroxynonenal also inhibits glucose-induced insulin secretion from pancreatic islets (29) , this supports the idea that the toxicity of Q 0 may be related in part to covalent attack of the dihydrolipoamide sulfhydryls of the E2 components of PDC and KDC but that its ability to stimulate insulin release involves another mechanism, possibly by causing massive release of calcium from mitochondria (1, 2).
The results suggest that studies of mitochondrial physiology with Q 0 , because of its multiple effects, need to be interpreted carefully; more importantly, these results might have implications for human autoimmune disease. They further support the idea that unphysiologic post-translational modification of protein thiols can create an abnormal protein. This may initiate an immunogenic response against the protein (30) , as in primary biliary cirrhosis, which is an autoimmune disease in which the major immune epitopes are the lipoyl domains of the E2 proteins of PDC and KDC (31, 32) .
